To provide an anti-inflammatory drug, a muscle-strengthening agent, an anti-hepatitis agent, an anti-inflammatory bowel disease agent, an anti-functional intestine disorder agent, an anti-functional liver disorder agent, an anti-functional kidney disorder agent or an anti-diarrhea agent, which are characterized by comprising: A cholic acid; B soybean isoflavone or soybean isoflavone glucoside; and C curcumin.
This applied invention relates to an anti-inflammatory drug, a muscle-strengthening agent, an anti-hepatitis agent, an anti-inflammatory bowel disease agent, an anti-functional intestine disorder agent, an anti-functional liver disorder agent, an anti-functional kidney disorder agent, or an anti-diarrhea agent, which are characterized by comprising: A cholic acid; B soybean isoflavone or soybean isoflavone glucoside; and C curcumin.
DAICHO TAKAO
TSUJI KUNIRO
NUKAYA HARUO
MIURA OTO
JP2001086931A | 2001-04-03 | |||
JPH06227974A | 1994-08-16 | |||
JPH0937736A | 1997-02-10 | |||
JPH11221048A | 1999-08-17 |
US4842859A | 1989-06-27 |
JPN6014050664; Biochem Pharmacol 58(7), 1999, 1167-1172
JPN6014050665; J. Agric. Food Chem. 49(4), 200104, 1767-1772
JPN6014050669; Proceedings of the Society for Experimental Biology and Medicine 217(3), 1998, 351-357
JPN6014050671; Molecular and Cellular Biochemistry 181(1/2), 1998, 87-96
JPN6014050672; British Journal of Pharmacology 129(2), 2000, 231-234
JPN6014050674; Cancer Research 55(2), 1995, 259-266
JPN6014050676; 新薬と臨床 48(9), 1999, 1206-1217
JPN6014050677; 臨床と薬物治療 15(5), 199605, 432-434
Next Patent: HMG1 ANTAGONIST FOR TREATING INFLAMMATORY SYMPTOMS